Medicine & Life Sciences
Hyaluronoglucosaminidase
Paroxysmal Hemoglobinuria
Anticoagulants
betrixaban
Hyaluronic Acid
Extracellular Vesicles
eculizumab
Thrombin
Glycocalyx
Thrombosis
Protein-Tyrosine Kinases
Dabigatran
Hyaluronidase Deficiency
Blood Platelets
BM 27
Abdominal Aortic Aneurysm
Therapeutics
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
peptidase 7
Inflammation
Hemostasis
factor XIIa inhibitor
Dasatinib
ponatinib
edoxaban
Clinical Studies
Torsemide
Longitudinal Studies
Activated Protein C Resistance
Factor XIIa
Pharmaceutical Preparations
Nanocapsules
Apigenin
Coumarins
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Thrombotic Microangiopathies
Atherosclerosis
Endothelial Cells
Arachidonate 5-Lipoxygenase
Diabetic Angiopathies
Lipoxygenase Inhibitors
Safety
Factor Xa Inhibitors
Nasal Polyps
Databases
BM 144
Sarcopenia
Extracellular Matrix
Tandem Mass Spectrometry
Charcoal
Patents
BM 34
Experimental Diabetes Mellitus
Leukotrienes
Thrombophilia
Thromboxanes
Routine Diagnostic Tests
Structure-Activity Relationship
Disseminated Intravascular Coagulation
Asthma
Kidney
Blood Coagulation Factors
Prothrombin Time
Peptide Hydrolases
BM 11
Vitamin K
ATP Binding Cassette Transporter, Subfamily B, Member 1
Acetaminophen
Contraceptive Agents
varespladib methyl
Child Development
BM 20
Colitis
Polyps
Blood Vessels
Wounds and Injuries
Drug Delivery Systems
Diuretics
Thromboxane A2
apixaban
Cystic Fibrosis
Anticonvulsants
Prostaglandins
Public Health
Financial Management
Fatty Acids
Chronic Disease
Rupture
High Pressure Liquid Chromatography
Cell Survival
Hemolysis
Leukemia
Edema
Intercellular Signaling Peptides and Proteins
Lipoxygenases
Pharmacovigilance
Rivaroxaban
In Vitro Techniques
Fibrosis
Chemical Compounds
Assays
Coagulation
Platelets
betrixaban
Chromogenics
Plasmas
Protein C
Anticoagulants
silicon carbide
factor XIIa inhibitor
Rats
Coumarins
Serum Globulins
Nanoparticles
Hyaluronoglucosaminidase
Surgery
Factor XIIa
Public health
Thromboxanes
Standardization
Contraceptive Agents
Dabigatran
Medicine
Thrombin
Prostaglandins
Factor Xa Inhibitors
Hypothermia
Drug interactions
Blood
Hyaluronic Acid
Steroids
Monitoring
Tranexamic Acid
Pharmaceutical Preparations
Thromboxane A2
Fondaparinux
Medical nanotechnology
Protein S
N-terbutyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea
Heparin
Warfarin
Marketing
Macrophages
Aspirin
Low Molecular Weight Heparin
Tissue
Chemical activation
Dilution
factor V Leiden
Endothelial cells
Animals
Buffers
Factor Xa
Nanostructured materials
Crystal structure
Enzyme Precursors
Crystalloid Solutions
Cyclooxygenase Inhibitors
Scaffolds
Colloids
Molecular weight
SiO2 nanoparticles